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Abstract:  
Purpose: To  describe the development and feasibility of a self-management intervention called the 
Help to Overcome Problems Effectively (HOPE: MS) intervention, aimed at  improving the physical 
and psychological wellbeing of people living with Multiple Sclerosis  (MS).  
Method:  HOPE: MS is an innovative, six week group-based, manualised self-management 
intervention combining positive psychology theory and practice and  cognitive behavioural therapy 
(CBT).  Participants  (N=21) recruited via a local East Midlands branch of the MS Society    attended 
one of  three HOPE: MS interventions and completed self-reported outcome measures  in week 1 
and week 6. The following outcome measures were used: The Multiple Sclerosis Impact Scale;  
Multiple Sclerosis Fatigue Severity Scale;  The Multiple Sclerosis Self-Efficacy Scale;  The Adult State 
Hope Scale; The Hospital Anxiety and Depression Scale;  The Positive and Negative Affect Scale. 
Results: Post-intervention ( 6 weeks) mean scores decreased in  the physical impact (baseline 
M=65.6, SD=17.4; 6 weeks M=55.1, SD=17.9, 95% CI [-4.39, -16.47] and  the psychological impact of 
MS (baseline M= 24.0, SD=7.3; 6 weeks M=18.9; SD=6.3, 95% CI [-2.54, -7.66]). There was also 
decrease in the mean fatigue severity scores  (baseline 49.4, SD=13.3, 6 weeks M=41.1, SD=14.4, 
95% CI [-2.65, -13.44]). There was a mean decrease in depression scores  (baseline M=6.9, SD=3.5; 
6 weeks M=4.2, SD=2.8,  95% CI [-1.43, -4.00]). There were smaller mean decreases in  anxiety 
(baseline M=7.6, SD=3.4; 6 weeks M=6.7 (4.0), 95% CI [0.69, -2.50]) and negative affect (baseline 
M=22.9, SD=6.8; 6 weeks M=20.8 (8.1), 95% CI [0.69, -2.50]) see table 3).   Mean MS self-efficacy 
scores (baseline 21.7, SD=4.2; 6 weeks M=24.1, SD=4.7, 95% CI [0.23, 4.53]), mean total hope scores 
(baseline M=23.3, SD=10.7; 6 weeks M=32.2 (10.6), 95% CI [4.91, 12.9]), hope agency scores 
(baseline M=10.5, SD=5.7; 6 weeks M=15.7 (6.2),  95% CI [2.37, 8.01]).hope pathways (baseline 
M=12.9, SD=6.0; 6 weeks M=16.6 (4.9), 95% CI [2.00, 5.43]) and positive affect scores increased 
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(baseline M=27.3, SD=7.1; 6 months M=32.2, SD=8.4, 95% CI [0.42, 9.39]).  Participants positively 
rated the intervention quality and delivery.    
Conclusions:  This feasibility study showed that the HOPE: MS was acceptable and useful to people 
living with MS.  Further robust evaluations using an randomised controlled trial design with longer 
follow ups are needed  to confirm early promising results of the HOPE: MS   
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Implications for rehabilitation:  
1. Living with MS requires constant adjustments to cope with unpredictable symptoms. 
2. Self-management interventions have the potential to help people living with Ms to improve 
their quality of life  
3. A feasibility study of the HOPE: MS self-management group-based intervention showed that 
it was acceptable and useful to people living with MS.   
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Introduction   
Multiple sclerosis (MS) is a chronic, progressive and currently incurable disease of the central 
nervous system, characterized by autoimmune inflammation, demyelination, and axonal damage 
[1]. MS etiology remains unknown, however an interaction between complex genetic factors and 
environmental influences seems to play a major role [1]. It is estimated that MS affects more than 2 
million people worldwide [2] and approximately 127,000 adults in the UK [3], and is the most 
common cause of neurological disability among young adults. MS symptom experience and 
symptom severity vary, depending upon the area of the brain in which lesions occur, thus no two 
cases of MS are exactly alike. Patients with relapsing-remitting MS after relatively symptom free 
periods experience flare-ups in which duration and severity is highly unpredictable, while in 
secondary progressive MS the disease progresses continuously without remission [1].   
The most common MS symptoms include spasticity, weakness, tremor, balance and mobility 
problems, bladder and bowel dysfunctions, sexual dysfunctions, speech difficulties, swallowing 
difficulties, and cognitive impairment [4]. The majority of people living with MS also experience 
severe fatigue [5] and depression [6]. It is estimated that up to 55% of people living with MS 
experience major depression in their lifetime [7]. Depression in MS has been associated with 
breakdowns in interpersonal relationships and employment, cognitive impairment, decreased 
adherence to treatment and greater suicide risk [7].  
 
Living with MS requires constant adjustments and the development of strategies to effectively cope 
with a wide array of unpredictable symptoms of the disease to maintain best possible health and 
quality of life [8]. The US Institute of Medicine describes self-management as “the tasks that 
individuals must undertake to live with one or more chronic conditions. These tasks include having 
the confidence to deal with medical management, role management and emotional management of 
their conditions.” [9].  Some of the main self-management skills include problem solving, decision 
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making, resource utilization, formation of a patient-provider partnership, action planning, and goal-
setting [10]. 
 
As indicated in a report by the Consortium of Multiple Sclerosis Centres [11] participation in self-
management support interventions is particularly important for people with MS. There is a large 
evidence base showing  that MS self-management interventions underpinned by cognitive-
behavioural approaches are effective in reducing depression [7, 12-15], stress [5, 16-19], perceived 
severity and impact of MS symptoms including fatigue and pain [20-22], and improving quality of 
life in people with MS [23].  
 
The aim of this  feasibility study was to evaluate the  acceptability and usefulness of a self-
management intervention called the Help to Overcome Problems Effectively (HOPE: MS) 
intervention in improving the physical and psychological wellbeing of people living with MS.  
 
 
HOPE:MS intervention underpinning theory 
HOPE: MS  is underpinned by positive psychology theory and research. We pursued this 
innovative approach to developing HOPE: MS because our evaluations of self-management 
interventions for other long term conditions  identified a renewed sense of hope,  a striving 
to use personal strengths in the pursuit of living well.   [24-26]. Positive psychology is 
concerned with the full range of human functioning and has the dual aims of alleviating 
psychological distress and promoting positive well-being. Professor Martin Seligman is 
attributed as responsible for officially launching positive psychology as a scientific 
endeavour during his American Psychological Association Presidential Lecture in 1998.   
However, as many others have noted, applied positive psychology has a research tradition 
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which spans decades . Linley  & Joseph,(2004)[27] point out that   cognitive behavioural 
therapists  have a long tradition of using positive psychological  techniques.  Lopez, Edwards, 
Magyar-Mor, Pedrotti, & Ryder(2003) [28] have described the potential usefulness of positive 
psychology to complement  CBT  because of the shared focus on a  strengths approach to 
adjustment and development of the two approaches. Karwoski et al (2006) [29] suggest that 
there is considerable conceptual and technical overlap between CBT and positive 
psychological approaches including developing a strong therapeutic relationship between 
client and therapist/coach; focusing on goals; cognitive reappraisal/mindfulness; scheduling 
pleasant activities; identifying and reviewing successes; monitoring mood; relaxation 
training and  problem solving.    
 
Snyder’s hope theory [30] and Fredrickson’s Broaden and Build theory [31] underpin HOPE: 
MS.  Although hope theory is similar to self-efficacy theory, there are important differences 
[32]. Whereas self-efficacy theory focuses on specific goals and behaviours, hope theory 
recognises enduring cross-situational goals and behaviours, and is therefore highly relevant 
to the broader task of managing the diverse impact of living with a long term condition. 
Further, self-efficacy theory emphasises the role of agency beliefs, whereas hope theory 
proposes a cognitive set that includes both agency (‘goal directed determination’) and 
pathways (‘planning of ways to meet goals’) [32]. Hope has been conceptualised and defined 
as “cognitive set that is based on a reciprocally-derived sense of successful agency (goal-
directed determination) and pathways (planning to meet goals)” [32]. As can be seen from 
Snyder’s definition, goals are fundamental to hope theory. Pathway thoughts describe the 
perceived ability to produce plausible routes to goals, whereas agency thought is the 
motivational element, which focuses on commencing and persevering with goal pursuits. 
Pathway and agency thoughts are iterative and additive [32].   
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A distinct feature of HOPE is a focus on an upward spiral of positive emotions [33] and 
experiences leading to greater well-being, resilience and coping. This contrasts with the 
more common approach used in other self-management interventions ( e.g. the Expert 
Patient Programme [34])  that introduce a negative spiral of fear and frustration leading to 
negative health and wellbeing.  Fredrickson (1998) suggests that increasing positive 
emotions and states is an efficient and often preferable approach to reducing negative 
emotions (35).  Fredrickson’s broaden and build theory (1998) (35) suggests that positive 
emotions broaden an individual’s attention, thinking and action thus enabling the building 
of new, creative thought and action pathways (i.e. expanding an individual’s coping skills), 
and  the building of personal and social resources.    
 
There is a growing body of evidence that suggests that gratitude improves psychological 
well-being and increases positive emotions  (e.g. McCullough, Tsang & Emmons, 2004 (36]; 
Wood, Maltby, Stewart & Linely, 2007 [37]). There have been a number of studies that have 
shown that interventions that increase gratitude are a promising clinical intervention for 
improving psychological well-being, but perhaps most significantly, depression . There have 
been calls for further research into gratitude interventions as they could be more widely 
used in clinical settings (Bono & McCullough, 2006 [40];).  A gratitude activity is a weekly 
feature in the HOPE: MS intervention.  It is designed to increase participants’ positive 
emotions.   HOPE: MS also includes other evidence-based CBT and positive psychological 
activities such as identifying personal strengths, scheduling pleasant activities, mindfulness, 
relaxation training and reviewing successes [29]. See Table 1 for HOPE: MS weekly content. 
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HOPE: MS utilises Irvin Yalom’s (2005) group curative factors, including instillation of hope, 
universality (realising you are not alone), and altruism [39]. Participants observe each other 
and the facilitators successfully overcoming the challenges of living with MS through  
achieving their weekly goals (instillation of hope), share  common experiences   
(universality) and are encouraged to support each other through the provision of 
informational and emotional support  (altruism). 
 
Development of the HOPE:MS intervention 
The HOPE: MS was developed with funding from the MS Society through their Small Grants 
Innovation Award Scheme.  The MS Society is a UK charity providing information and support for 
people living with MS.  Development and feasibility testing of HOPE: MS was guided by the MRC 
framework for developing and testing complex intervention [40].  HOPE and involved  consultations 
with MS health professionals and people living with MS.  HOPE: MS is a group-based self-
management intervention delivered in six weekly sessions each of 2.5 hours’ duration. Two 
HOPE: MS interventions were delivered to 14 participants  in total and feedback obtained 
from  five  participants and three facilitators via focus groups and interviews about how to 
improve the process and content of the intervention.   HOPE: MS was found to be acceptable 
in terms of format, content and delivery.  Participants and facilitators mentioned that the 
most valued aspects of the intervention were goal setting and action planning,  deep 
breathing exercises, and sharing and learning with similar others.  For some participants the 
HOPE: MS intervention allowed them to be more positive about living with MS, particularly in 
terms of encouraging them to think about their strengths.   Participants valued having the 
opportunity to share and learn with similar others.  Participants felt supported and 
understood by the facilitators who had experienced and overcame similar challenges.   
Several changes were made to the intervention on the basis of this formative evaluation, 
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including a more comprehensive and MS specific physical activity and fatigue management 
component, and the addition of an “open space forum” session in week 6. The focus of the 
“open space forum” would  be selected by the  group and could address any specific concerns 
the group  had which had  not been covered in the intervention curriculum. Invited speakers 
could also contribute to this session.   Other changes made to the intervention included using 
more interactive learning materials and activities such as information and educational 
videos (e.g. “The  Science of Character”;  
https://www.youtube.com/watch?v=U3nT2KDAGOc) quizzes,  fatigue and pacing  diaries,  
physical activity case studies, and communication skills role playing)  in the intervention 
delivery.  
 
HOPE: MS content and delivery  
Two people living with MS who had previous experience of delivering self-management 
interventions for the MS Society in the UK were recruited to deliver the HOPE: MS. Each 
session follows a similar pattern. There is a combination of psycho-education, skills practice, 
in-depth group discussion,  and setting and reviewing goals Participants set personally 
relevant and meaningful weekly goals, as ‘homework’ tasks which they were invited to share 
with other group members and  provide  goal attainment or goal barrier feedback the 
following week. Goal setting and action planning are  key behaviour change techniques that 
have a strong evidence base [41-42].Other ‘homework’ tasks include completing a fatigue 
and pacing diary and taking an online  character strengths test.  
 
Insert table 1  about here 
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HOPE: MS Facilitator Training 
Facilitator training encompasses a 2 day classroom-based training course.  The classroom 
training involves training in motivational interviewing (e.g. reflective listening) and 
behaviour change skills (e.g. goal setting, action planning), group facilitation skills (e.g. 
managing challenging behaviours) and delivery practice of intervention activities.  Delivery 
is guided by a tutor’s manual to ensure consistency of delivery and content.  Facilitators  
were  trained and accredited against a rigorous set of quality standards with training and 
intervention delivery focusing on adherence to the timing, sequence and coverage of 
activities as set out in the manual to ensure ﬁdelity.   Facilitators were observed delivering   a 
session from the first HOPE:MS intervention and assessed using a fidelity checklist.    
Ongoing support was provided by one of the authors (AT) and the lead HOPE facilitator 
trainer, both of whom are experienced  self-management trainers, having trained over 500  
peer and professional facilitators.     
 
Feasibility study 
Participants were recruited via a local East Midlands branch of the MS Society at drop in sessions 
and the branch’s  annual conference.  People living with MS were informed that the 
intervention would provide the opportunity to learn how to better manage their MS and to  
meet other people living with  MS in a supportive  group setting.  In total 25 people living 
with MS expressed an interest in attending the intervention and provided contact details.  
Four participants subsequently decided not to participate, because the  timing of the 
intervention was inconvenient due to either holiday   (N=1)or  work commitments (N=1), or  
feeling  unwell (N=2).   
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The following inclusion/exclusion criteria were established:  
Inclusion Criteria: 
 Diagnosis of any type of MS confirmed by neurologist. 
 Aged 18 years and over. 
 Ability to complete a questionnaire. 
 
Exclusion Criteria: 
 Inability to understand and participate in an intervention delivered in English. 
 Current participation in any other research study. 
 
Procedure 
Three HOPE interventions were delivered sequentially over a 12 month period. No changes 
were made to the intervention during this period.  Participants completed outcome measures 
during session one (baseline) and session six (post intervention). A self-management 
intervention  quality and delivery rating scale  was completed  during the last session of the 
intervention. 
Outcome measures 
Demographic information such as age, gender, ethnicity, type of MS and co-morbidity, was collected 
at baseline only (see Table 2 for demographic variables). We used a range of outcome measures 
selected to best capture self-management outcomes relevant for people living with MS.  
The Multiple Sclerosis Impact Scale (MSIS-29) [43] has 29 items; 21 relating to the physical 
impact of the condition (e.g., difficulties moving about indoors) and 8 relating to psychological 
impact (e.g., feeling anxious or tense).  The timeframe for completion is 'in the previous two weeks' 
and each item is rated on a scale anchored at 1 (not at all) and 5 (extremely); Scores for physical 
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and psychological impact are summed separately with higher scores indicating greater physical and 
psychological limitations.  
The Multiple Sclerosis Fatigue Severity Scale [44] contains 9 items relating to fatigue within the 
previous week with each item rated on a scale anchored at 1 (strongly disagree) and 7 (strongly 
agree) with higher scores indicating higher levels of fatigue. Example items include:  Fatigue 
interferes with my physical functioning; Fatigue causes frequent problems for me. 
 
The Multiple Sclerosis Self-Efficacy Scale [45] was used to determine the level of self-efficacy 
(confidence) each participant had in the previous week.  Each of the 11 items is rated 1 (strongly 
agree) to 4 (strongly disagree); higher scores reflect greater self-efficacy.  Example items include: 
Despite my difficulties, I still manage to cope with daily life;  I am confident I can overcome my 
difficulties.  
The Hospital Anxiety and Depression Scale (HADS) [46] comprises 14 items; 7 assessing anxiety 
(e.g., Worrying thoughts go through my mind ) and 7 assessing depression (e.g., : I look forward with 
enjoyment to things).  Each item is rated 0 to 3, with anxiety and depression items  summed 
separately with scores ranging from 0 to 21; higher scores indicate higher anxiety and depression.  
 
The Positive and Negative Affect Scale (PANAS) [47] assesses positive and negative affect.  The 
scale comprises 20 words, 10 describing positive affect (e.g., interested, excited) and 10 describing 
negative affect (e.g., upset, guilty). Each word is rated 1(very slightly or not at all) to 5 (extremely) 
indicating to what extent the participant had felt each emotion in the previous week.  Scores for 
positive affect and negative affect are summed separately; higher scores indicate higher levels of 
positive and negative affect.  
 
The Adult State Hope Scale [48] measures hope defined as the perceived “capability to derive 
pathways to desired goals, and motivate oneself via agency thinking to use those pathways” [36]. 
The scale comprises 6 statements which represent pathways (e.g., There are lots of ways around any 
problem that I am facing now.) and agency (e.g., At the present time, I am energetically pursuing my 
goals ) beliefs. Participants indicate the extent to which they agree with each of the 6 statements on 
scale anchored at 1 (definitely false) and 8 (definitely true).  Overall scores range from 6 to 48 with 
higher scores indicting higher levels of hopeful thinking. Scores for the Agency and Pathways 
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subscale items are summed separately to provide scores between 3 and 24, with higher scores 
indicating more agency and pathways beliefs. Intervention quality and delivery rating scale 
 
The Health Education Impact Questionnaire (heiq) is a 9 item scale [49] which assesses self-
management intervention quality, and has been used  to evaluate  self-management 
interventions in the UK [50] and Australia [49]. Participants completed the heiq scale during 
the last session of the intervention. Responses to each of the 9 items are scored: 1 = Strongly 
Disagree, 2= Disagree, 3= Agee, 4= Strongly Agree.   Higher scores indicate more positive 
feedback. Scores are averaged to provide a mean score for each item between 1 and 4.  
Example items include:  “I intend to tell other people that the intervention is very worthwhile.”; 
“The content was very relevant to my situation.”  
 
The study was approved by Coventry University Ethics Committee. 
 
Data analysis 
All data analyses were conducted using IBM SPSS Statistics 20.   Descriptive statistics, mean (SD) 
and 95% CI are presented for  baseline and post-intervention outcomes in keeping with 
studies with small sample sizes, which are not adequately powered for hypothesis testing 
[51]. 
RESULTS  
All 21 participants completed the intervention (17 participants attended all  6 sessions; 2 
attended 5 sessions and 2 attended 4 sessions)  and completed baseline and post-intervention 
outcome measures.) 
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Demographic variables 
All respondents were of White ethnic origin and a majority were women (81%, n=17). Participants 
mean age was 54.3 years (SD 10.5 years; age range 36-76 years). Twelve respondents had 
relapsing-remitting MS, eight secondary progressive MS and one participant had benign MS. Just 
under half of respondents (43%, n=9) had a co-morbid health condition in addition to MS. 
Participants’ characteristics are summarised in table 2. 
 
Insert table 2  about here 
Outcomes 
Participation in HOPE: MS was associated with improvements in all MS-specific outcome 
measures. Table 3 shows that at the end of the 6 week intervention mean scores decreased in 
both the physical impact (baseline M=65.6, SD=17.4; 6 weeks M=55.1, SD=17.9, 95% CI [-
4.39, -16.47])and the psychological impact of MS (baseline M= 24.0, SD=7.3; 6 weeks M=18.9; 
SD=6.3, 95% CI [-2.54, -7.66]), as measured by MSIS-29. There was also a decrease in mean 
fatigue severity scores   (baseline 49.4, SD=13.3, 6 weeks M=41.1, SD=14.4, 95% CI [-2.65, -
13.44]) and mean MS self-efficacy scores increased   (baseline 21.7, SD=4.2; 6 weeks M=24.1, 
SD=4.7, 95% CI [0.23, 4.53]). 
 
Participation in HOPE:MS was also associated with  a mean decrease  in  depression scores  
(baseline M=6.9, SD=3.5; 6 weeks M=4.2, SD=2.8,  95% CI [-1.43, -4.00]), increase  in mean  
total hope scores (baseline M=23.3, SD=10.7; 6 weeks M=32.2 (10.6), 95% CI [4.91, 12.9]), 
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hope agency scores (baseline M=10.5, SD=5.7; 6 weeks M=15.7 (6.2),  95% CI [2.37, 
8.01)]hope pathways (baseline M=12.9, SD=6.0; 6 weeks M=16.6 (4.9), 95% CI [2.00, 
5.43]and positive affect (baseline M=27.3, SD=7.1; 6 months M=32.2, SD=8.4, 95% CI [0.42, 
9.39]). There were smaller mean decreases in anxiety (baseline M=7.6, SD=3.4; 6 weeks 
M=6.7 (4.0), 95% CI [0.69, -2.50]) and negative affect (baseline M=22.9, SD=6.8; 6 weeks 
M=20.8 (8.1), 95% CI [0.69, -2.50]) see table 3).   
 
Course quality and delivery 
Table 4 shows that the mean ratings for all 9 items was 3.6 or above, indicating that 
participants rated the HOPE intervention delivery and quality positively. 
Insert table 4  about here 
DISCUSSION 
To the best of our knowledge this is the first study to look at whether a self-management 
intervention developed combining  positive psychology and CBT theory and practice  is 
acceptable and  if it has the potential to be useful  for people living with MS.   All 21 
participants completed pre and post-intervention outcome measures and attended at least 4 
sessions, which indicates the intervention is acceptable for people living with MS .  The 
outcome measures reflected important aspects of living with MS including  fatigue, anxiety, 
depression and physical limitations.  In keeping with the positive psychological theory 
underpinning the intervention we also used outcome measures which assessed positive  
affect and.   Mean scores on all of the outcome measures improved and these improvements 
are in line with other feasibility trials we have conducted with HOPE interventions for cancer 
survivors  [52] people living with HIV [53]  and parent caregivers  [N=54]] .  The scale of the 
improvements are also consistent with randomized controlled trials of  self-management 
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interventions  for people living with a range of  long-term conditions,  of a similar duration 
(6 weeks) delivered by peer facilitators [34, 47, 55].   
 
Positive psychology interventions should address illnesses that affect longevity, disability,  
have  a  variable prognosis and can  involve a relapse [56].   Recently, self-management 
researchers have emphasised the importance of fostering hope and other positive 
psychological emotional states in supporting people to manage their condition [57-58].  
 
Interventions  such as HOPE: MS that  have the potential   to reduce depression associated with MS 
can potentially prevent the development of severe mood disorders, help reduce demand placed on 
psychological services and reduce healthcare costs. Several hope therapy based studies [59,60]  
involving older depressed adults in the United States reported a statistically significant increase and 
large effect size improvement in hope and reduced feelings of hopelessness, anxiety and depression.   
Chronic fatigue is considered by people affected by MS to be the most debilitating symptom and 
leads to most disruption in their everyday activities [61]. Improved self-management of fatigue can 
enable people living with MS to lead a more active life and as a result significantly improve patients’ 
quality of life.   MS self-efficacy, positive affect and hope scores all improved.  Studies show that MS 
self-efficacy is an important predicator of self-reported physical, social and cognitive functioning in 
MS and plays a significant role in individual psychological adjustments to MS [62].  The 
improvements in positive affect and hope are important as they reflect the positive psychological 
theoretical underpinnings of HOPE: MS.   High positive affect refers to a general tendency to 
experience a "state of high energy, full concentration, and pleasurable engagement"[48]. We have 
described elsewhere the important role positive emotions have among participants attending self-
management interventions in helping them cope [63].  Moreover focusing, on positives is one of  the 
predicators of better psychological adjustment to MS, higher levels of energy and reduced fatigue 
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[13]. MS is often associated with loss of hope that can lead to depression [12]. Hope (goal directed 
agency and planning) has been shown to be a unique predictor of  general wellbeing  [64]  
Mean changes in anxiety and negative affect were smaller than the other outcomes.  In an evaluation 
of an arthritis self-management intervention we reported improvements in positive affect but not 
negative affect, at 12 months, similar to the results of this study [65]. Women with MS are 
particularly prone to anxiety disorders [66], and since our sample included mostly females, we may 
speculate that they were more likely to experience some form of anxiety. Many studies have 
assessed the effectiveness of different kinds of interventions in reducing depression in people living 
with MS [7], however studies examining the effectiveness of interventions in reducing anxiety are 
scarce thus it is difficult to speculate why  mean improvements in anxiety scores  were  not  similar 
to other outcome measures.   Further studies are needed to determine what self-management 
interventions components are associated with  lower anxiety.  
 
The results of the heiq intervention quality and delivery  report are positive and  suggest that 
overall participants are satisfied with the quality of the SMP and the delivery style and skill of the 
tutors  are similar to those reported by a large scale UK evaluation of  a similar type of peer led self-
management intervention [49].  
 
Limitations 
The mean differences between pre and post-course were generally high, which is promising, 
but need to be interpreted with caution for several reasons. The study had a small sample 
size, and was uncontrolled. Only baseline and  post intervention data were collected so we 
are unable to say whether the improvements are maintained in the longer term.   The sample 
was self-selected, highly motivated,  and  homogenous,  with all participants being of White 
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ethnic origin and the majority  were women. It is possible that this self-selected group have a 
natural inclination to respond favourably to a positive psychological approach to managing 
their MS.     
Post intervention outcomes were collected during the last session in the presence of the 
facilitators, which introduces the risk of bias as participants may experience the Hawthorne 
effect [67]t and give overly positive outcome scores.  Further, the response time for some of 
the outcome measures meant that participants based their responses on a period before the 
intervention ended (e.g.  PANAS, previous week,  MSIS-29, previous 2 weeks).  Finally, we did 
not collect any information about disease duration or level of disability.   
 An adequately powered, randomized controlled trial is needed to establish whether  HOPE: 
MS  has the potential to provide  longer term positive effects and whether it is acceptable and 
useful in the long-term  ( 6-12 months follow up). The sample should include   participants of 
different ethnic origins, different types of MS, including those with primary progressive MS 
and men. 
 
Conclusion 
HOPE: MS is an innovative self-management intervention combining positive psychology 
theory and practice and CBT.  The intervention was acceptable and useful for people living 
with MS and the quality of delivery was  positively rated.    Further robust evidence is needed 
of the impact of the HOPE: MS  self-management  intervention. 
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Tables:  
Table 1 HOPE:MS Intervention Content   
Session Number  Session Activities  
Session 1 Welcome, introduction and ground rules  
 
What is self-management?  
Instilling hope: The upward spiral of positivity 
 
Diaphragmatic breathing  
Gratitude diary 
Goal setting and action planning 
 
 
  Session 2 Welcome and reflections from last week’s session 
 
Solution focused goal feedback 
 
Gratitude diary 
 
Managing stress 
 
Introduction to mindfulness  
Goal setting and action planning 
 
 
Session 3 Welcome and reflections from last week’s session 
 
Solution focused goal feedback 
 
Gratitude diary 
Managing fatigue 
Managing emotions 
Guided imagery 
Goal setting and action planning 
 27 
 
Session 4 
Welcome and reflections from last week’s session 
Solution focused goal feedback 
Gratitude diary 
Body image, sexuality and intimacy 
Communication 
Goal setting and action planning 
 
 
  
 
Welcome and reflections from last week’s session 
Session 5 Solution focused goal feedback 
 
Gratitude diary 
Fear of relapse and disease progression 
Move and feel good 
Goal setting and action planning 
 
 
 
  Session 6 Welcome and reflections from last week’s session 
 
Solution focused goal feedback 
Gratitude diary 
Character strengths 
Life priorities 
Motivational imagery 
Sharing successes 
Moving on and staying in touch 
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Table 2: Demographic characteristics of participants 
Characteristics N Mean (SD)  
Age: Mean (SD=standard deviation, range)  21 54.3 (10.5) ( 36-76) 
  % 
Gender: 
Male 
Female 
 
 
4 
17 
19 
81 
Ethnic origin: 
White 
 
 
21        100 
Type of MS: 
Relapsing-remitting 
Secondary progressive 
Benign 
 
 
12 
8 
1 
57.1 
38.1 
4.8 
Co-morbidity 9 43 
 
Table 3: Changes in outcome measure scores ( mean, (SD) [95% CI]) pre and 6 weeks post HOPE:MS 
intervention 
Measure Mean (SD) 
baseline 
Mean (SD)  
6 weeks 
95% CI 
MSIS: Physical (21-105, ↓ = better) 
MSIS: Psychological (8-40, ↓ = better) 
MS: Fatigue Severity (9-63, ↓ = better) 
65.6 (17.4) 
24.0 (7.3) 
49.4 (13.3) 
55.1 (17.9) 
18.9 (6.3) 
41.4 (14.4) 
[-4.39, -16.47] 
[-2.54, -7.66] 
[-2.65, -13.44] 
MS: Self-Efficacy (11-44,↑ = better)  21.7(4.2) 24.1(4.7) [0.23, 4.53] 
HADS: Anxiety  (0-21, ↓ = better) 
HADS: Depression (0-21, ↓ = better) 
PANAS: Positive Affect (10-50, ↑ = better)  
PANAS: Negative Affect (10-50,↓ =better) 
7.6 (3.4) 
6.9 (3.5) 
27.3 (7.1) 
22.9 (6.8) 
6.7 (4.0) 
4.2 (2.8) 
32.2 (8.4) 
20.8 (8.1) 
[0.69, -2.50] 
[-1.43, -4.00] 
[0.42, 9.39] 
[0.77, -4.87] 
HOPE total score (6-48, ↑ = better) 23.3(10.7) 32.2(10.6) [4.91, 12.9] 
HOPE subscale: agency 10.5 (5.7) 15.7 (6.2) [2.37, 8.01] 
HOPE subscale: pathways 12.9 (6.0) 16.6 (4.9) [2.00, 5.43] 
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Table 4  Participants'  rating of intervention quality and deliver rating ( mean, SD)  
 
Self-Management Intervention Quality Report items Mean 
(SD) 
I intend to tell other people that the intervention is very worthwhile 3.7 (4.6) 
The intervention has helped me set goals that are reasonable & within 
reach  
3.6 (0.5) 
I trust the information and advice obtained from progranne 3.7 (0.5) 
Intervention tutors very well organised 3.6 (0.6) 
I feel it was worth my time and effort to take part 3.8 (0.4) 
Difficult topics and discussions were handled well by tutors 3.8 (0.4) 
Content was very  relevant to my situation 3.7 (0.6) 
I feel that everyone in the intervention had the chance to speak if they 
wanted 
3.9 (0.3) 
The people in the group worked very well together 4.0 (0.0) 
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